OOIR: Observatory of International Research

Papers

(The H4-Index of JAMA Neurology is 75. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Diplopia and Ptosis in an Older Woman	660
Somebody to Love	452
Optimizing the Time Course of Risks and Benefits of Acute Dual Antiplatelet Therapy for Stroke Prevention	443
Error in Author Name	313
Early vs Delayed Extubation After Thrombectomy for Acute Ischemic Stroke	270
Risk of Dementia in Individuals With Emergency Department Visits or Hospitalizations Due to Cannabis	251
Itching Frequency and Neuroanatomic Correlates in Frontotemporal Lobar Degeneration	251
Early Access to First-Seizure Clinics, Subsequent Outcomes, and Factors Associated With Attendance	241
Substantia Nigra Pathology, Contact Sports Play, and Parkinsonism in Chronic Traumatic Encephalopathy	234
Ghrelin for Neuroprotection in Post–Cardiac Arrest Coma	233
Comparison Between Dimethyl Fumarate, Fingolimod, and Ocrelizumab After Natalizumab Cessation	227
Origin of Transthyretin in Cerebral Amyloid Angiopathy	218
Rizatriptan vs Placebo for Attacks of Vestibular Migraine	216
Automated Imaging Differentiation for Parkinsonism	215
Equipping AI for Unbiased and Inclusive Neurology	200
Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation	198
A Call to Action to Address Sex Differences in Alzheimer Disease Clinical Trials	195
Alternate Hemibody Hyperkinetic and Hypokinetic Movement Disorders Due to Strategic Lesions in Cerebral Toxoplasmosis	186
Reinterpreting Clinical Trials in Children With Multiple Sclerosis Using a Bayesian Approach	176
JAMA Neurology	174
Functional Outcomes in Conservatively vs Surgically Treated Cerebellar Infarcts	171
JAMA Neurology	159
Isosorbide Mononitrate and Cilostazol Treatment in Patients With Symptomatic Cerebral Small Vessel Disease	158
Is It Really Itching?	147
The Neurologist’s Imperative in Brain Death	145

External Carotid Artery Angioplasty Based on Ultrahigh-Resolution Photon-Counting CTA	144
Anticoagulation and Antiplatelet Therapy in Patients With Atrial Fibrillation and Atherosclerosis	138
Time From Hospital Arrival Until Endovascular Thrombectomy and Patient-Reported Outcomes in Acute Ischemic Stroke	131
Endovascular Therapy for Basilar Occlusions—The ATTENTION Trial	128
Thrombolysis With Tenecteplase for Minor Disabling Stroke	123
Time to Change the Current Clinical Classification of Multiple Sclerosis?	122
Teleneurorehabilitation and Motor and Nonmotor Symptoms and Quality of Life in Parkinson Disease	121
Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple Sclerosis	120
Effect of Neprilysin Inhibition on Alzheimer Disease Plasma Biomarkers	119
Error in Abstract	117
Error in Additional Contributions	117
Alzheimer Disease as a Clinical-Biological Construct—An International Working Group Recommendation	117
Histologic Anatomy of Neurocysticercosis	117
Spontaneous AICA Dissection Presenting With Isolated Audiovestibular Loss	116
Error in Figure	116
Wind Swirl Pattern on Density Spectral Array in Anti-GABAB Receptor Encephalitis With Amnestic Seizures	114
Functional Seizures—A Critical Comorbidity Overlooked in Epilepsy Research—Reply	114
Sleep Recording for the Diagnosis and Treatment of Paraplegia	113
Is It Really Itching?—Reply	107
Association of Cardiovascular Events With Spouse’s Subsequent Dementia	107
Spinal Cerebrospinal Fluid Leak Mimicking a Cerebellopontine Angle Tumor	105
JAMA Neurology	104
Tackling the Unmet Therapeutic Needs in Nonsurgical Treatments for Epilepsy	103
β-Amyloid Positron Emission Tomography Use Across Medicare Administrative Contractor Regions	103
Retinal Hemorrhage Associated with Human Granulocytic Anaplasmosis	103
Interhemispheric Bullet Migration—A Surgical Dilemma	102
Tilting at Treadmills—Pitfalls and Potential of Dementia Prevention Trials	99
Seizure Frequency Trends Over Time in Treatment-Resistant Focal Epilepsy	98
Five Years of Ublituximab in Multiple Sclerosis	96
Catheter Ablation and Oral Anticoagulation for Secondary Stroke Prevention in Atrial Fibrillation	90
Risk Factors Associated With Late-Onset Epilepsy in Dementia and Mild Cognitive Impairment	86
Intra-Arterial Tenecteplase After Successful Reperfusion in Large Vessel Occlusion Stroke	86
N-Acetylcysteine for Hereditary Cystatin C Amyloid Angiopathy	86
Do Neurologists Need a Goldwater Rule?	86
Contribution of Somatic Ras/Raf/Mitogen-Activated Protein Kinase Variants in the Hippocampus in Drug-Resistant Mesial Temporal Lobe Epilepsy	85
Neuronally Derived Extracellular Vesicle α-Synuclein as a Serum Biomarker for Individuals at Risk of Developing Parkinson Disease	85
Role of the X Chromosome in Alzheimer Disease Genetics	84
Prourokinase vs Standard Care for Patients With Mild Ischemic Stroke	84
Posttreatment Amyloid Levels and Clinical Outcomes Following Donanemab for Early Symptomatic Alzheimer Disease	83
Current and Future Roles of Chimeric Antigen Receptor T-Cell Therapy in Neurology	82
Endovascular Stroke Thrombectomy for Patients With Large Ischemic Core	82
GLP-1RA and SGLT2i Medications for Type 2 Diabetes and Alzheimer Disease and Related Dementias	82
JAMA Neurology	81
Error in Figures	78
Perceived CTE and Suicidality—Is Perception Reality?	78
Error in Text	78
Peripheral-Type Facial Paralysis and Unilateral Hemisphere Hemorrhage	77
Error in Key for Figure 3	77
A Rare Neurological Presentation of Kikuchi-Fujimoto Disease	76
Bibrachial Amyotrophy Due to Spontaneous Spinal Cerebrospinal Fluid Leak	75